Is Sermorelin Legal in Michigan? How to Access It Legally

HealthRX.com

No sermorelin product is FDA-approved, so all supply is compounded

Print or save as PDF

See the public record for Sermorelin

  • FDA-approved sermorelin / None; Geref approvals withdrawn in 2009 [1]
  • Products sold today / Compounded only, not FDA-reviewed [2]
  • FDA safety-risk bulk list / Sermorelin not listed [3]
  • Outsourcing-facility bulk list / Category 1, under evaluation [4]
  • State-licensed pharmacy bulk list / Not in any category [5]
  • HHS peptide enforcement draft / Sermorelin not among the six peptides [6]
  • Sport / WADA-prohibited at all times [7]
  • State-licensed pharmacy compounding / Requires a valid patient-specific prescription; an outsourcing facility may also distribute against a health care provider's order that is not for an identified patient [8]

Is Any Sermorelin Product FDA-Approved Today?

No. Sermorelin acetate reached the US market as Geref, under two applications: a 0.05 mg per ampule product approved December 28, 1990 for testing the pituitary's ability to secrete growth hormone, and 0.5 mg and 1 mg vials approved September 26, 1997 for treating idiopathic growth hormone deficiency in children with growth failure [1]. The manufacturer discontinued both in 2008 and asked FDA to withdraw the applications; FDA withdrew both approvals effective June 18, 2009 [1]. In March 2013 the agency determined that Geref was not withdrawn from sale for reasons of safety or effectiveness [1][9]. Those two applications are the only sermorelin applications in Drugs@FDA [1][9].

Approved use was narrow: pediatric growth hormone deficiency with growth failure, and a diagnostic test of pituitary growth hormone reserve. Geref was never approved for adults, anti-aging, weight loss or athletic performance [1].

What Is Sold as Sermorelin Now?

Compounded sermorelin. FDA states that compounded drugs are not FDA-approved [2]. Sermorelin itself is a 29-amino-acid analogue of growth hormone-releasing hormone, not growth hormone [10].

What Federal Rules Decide Whether It Can Be Compounded?

For a state-licensed pharmacy, FDA says one condition of the compounding exemption from FDA approval is that the drug is compounded on receipt of a valid patient-specific prescription [8]. Outsourcing facilities may distribute compounded drugs against a patient-specific prescription or in response to an order from a health care provider, such as a hospital, that is not for an identified individual patient [8]. FDA publishes a list of registered outsourcing facilities [11].

Sermorelin appears in no category on FDA's list of bulk drug substances for state-licensed pharmacies and physicians, updated May 14, 2026 [5]. FDA separately lists sermorelin acetate in category 1, under evaluation, on its list of nominated bulk substances for outsourcing facilities (updated March 21, 2025), marked with the list's symbol for substances that are components of FDA-approved drugs [4].

Two more markers: sermorelin is not on FDA's page of bulk substances that may present significant safety risks when compounded, content dated April 22, 2026 [3], and it is not one of the six peptides named in HHS's October 2026 draft enforcement-discretion policy [6].

What About Michigan's Own Rules?

The federal pages described above do not address Michigan law. Whether a particular Michigan prescriber, pharmacy or compounded product is legally permitted depends on state rules that these federal points cannot confirm.

Questions worth asking

Choose the questions you want to keep

Is Sermorelin Banned in Sport?

WADA's 2026 Prohibited List names sermorelin in S2.2.4, growth hormone releasing factors, prohibited at all times in and out of competition, and S2 substances are non-Specified Substances [7]. It is named again in the 2027 List, in force January 1, 2027 [12].

What Dose Is Approved?

None. With no approved product there is no approved dose [1]. The doses that have been studied are 30 micrograms per kg once daily subcutaneously at bedtime in the pediatric program, and 0.5 mg or 1 mg subcutaneously twice daily for 14 days in a study of 10 older men; neither is a recommended dose [13][14].

Is sermorelin legal in Michigan?
No FDA-approved sermorelin exists, so any product is compounded and not FDA-reviewed [1][2]. Federally, a state-licensed pharmacy's compounding exemption requires a valid patient-specific prescription [8]. Michigan's own pharmacy and prescribing rules are separate from these federal points.
Is any sermorelin product FDA-approved?
No. Geref, the only approved sermorelin, was discontinued in 2008 and FDA withdrew both applications effective June 18, 2009; the agency later determined it was not withdrawn for safety or effectiveness reasons [1][9].
Can a pharmacy compound sermorelin?
Federal information does not establish whether a particular state-licensed pharmacy may compound sermorelin. A valid patient-specific prescription is a condition of the federal compounding exemption [8]. Sermorelin appears in no category on FDA's list for state-licensed pharmacies and physicians [5]. FDA lists it as category 1, under evaluation, for outsourcing facilities [4], and it is not on FDA's significant-safety-risk list [3].
Do I need a prescription for sermorelin?
For a compounded product from a state-licensed pharmacy, FDA lists a valid patient-specific prescription as a condition of the federal compounding exemption [8].
Is sermorelin prohibited in sport?
Yes. WADA names sermorelin in S2.2.4 of its 2026 Prohibited List, banned at all times in and out of competition, and it appears again in the 2027 List [7][12].
What dose of sermorelin is approved?
None. With no approved product there is no approved dose; the studied doses were 30 micrograms per kg once daily at bedtime in children and 0.5 mg or 1 mg twice daily for 14 days in a small study of older men [13][14].
Show all 14 referencesHide references
  1. Federal Register :: Request Access.
  2. Official web page.
  3. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
  4. U.S. Food and Drug Administration.
  5. U.S. Food and Drug Administration.
  6. Official web page.
  7. World Anti-Doping Agency.
  8. Human Drug Compounding Laws | FDA.
  9. U.S. Food and Drug Administration.
  10. Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-57.
  11. Registered Outsourcing Facilities | FDA.
  12. World Anti-Doping Agency.
  13. Thorner M, Rochiccioli P, Colle M, Lanes R, Grunt J, Galazka A, et al. Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group. J Clin Endocrinol Metab. 1996;81(3):1189-96.
  14. Corpas E, Harman SM, Piñeyro MA, Roberson R, Blackman MR. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men. J Clin Endocrinol Metab. 1992;75(2):530-5.
Sermorelin legal Michigan: evidence summary chart
Image: HealthRX.com. Full sermorelin legal Michigan guide and sources at healthrx.com/peptide-legal-sermorelin.